Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: Highest burden for peripheral arterial disease

European Journal of Vascular and Endovascular Surgery

Volumn 43, Issue 2, 2012, Pages 198-207

  Smolderen, K G ^a,b   Wang, K ^a   De Pouvourville, G ^c   Bruggenjurgen B ^d,e   Rother J ^f   Zeymer, U ^g   Parhofer, K G ^h   Steg, P G ⁱ   Bhatt, D L ^j   Magnuson, E A ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b TILBURG UNIVERSITY   (Netherlands)

^c Department of Health Economics ^*  (France)

^d STEINBEIS UNIVERSITY BERLIN   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f ASKLEPIOS KLINIK ALTONA   (Germany)

^g Institut fur Herzinfarktforschung Ludwigshafen   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ BICHAT HOSPITAL   (France)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

Cerebrovascular disease; Coronary disease; Costs; Hospitalisation; Peripheral arterial disease

Indexed keywords

ADULT; AGED; AMPUTATION; ARTERY THROMBOSIS; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST OF ILLNESS; DISEASE REGISTRY; FEMALE; FRANCE; GERMANY; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVASCULARIZATION;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; CORONARY ARTERY DISEASE; COST OF ILLNESS; FEMALE; FOLLOW-UP STUDIES; FRANCE; GERMANY; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; THROMBOSIS;

EID: 84855553982     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.09.016     Document Type: Article

References (25)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
2. Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, et al. European cardiovascular disease statistics. European Heart Network; 2008.
3. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 2006;151. pp. 786e781-786e710.
4. Steg PG, Bhatt DL, Wilson PW, D'Agostino R, Ohman EM, Rother J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-206. (Pubitemid 46465728)
5. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, et al. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes 2008;1:38-45.
6. Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, et al. One-year costs associated with cardiovascular disease in Canada: insights from the REACH Registry. Can J Cardiol 2010;26:297-305.
7. Hirsch AT, Criqui AT, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24. (Pubitemid 33015522)
8. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda YA, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9. (Pubitemid 43076437)
9. Schulman K, Burke J, Drummond M, Davies L, Carlsson P, Gruger J, et al. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ 1998;7:629-38. (Pubitemid 28521901)
10. Echelle nationale des coÛts et coÛts de réfé rence en euros par GHM. http:// www.atih.sante.fr/openfile.php?id=448; 2003 [accessed 18.07.11].
11. Echelle privée de point ISAF par GHM. http://www.atih.sante.fr/ openfile.php?id=443; 2001 [accessed 18.07.11].
12. Weiterentwicklung des G-DRG-Systems für das Jahr 2004, Band 2: Fallpauschalen-Katalog, Klinische Profile, Kostenprofile. http://www.g-drg.de/ cms/content/download/990/6530/version/2/file/Abschlussbericht-G-DRG- V2004-0312191400-BII.pdf; 2003 [accessed 18.07.11].
13. Mahoney EM, Wang K, Keo HH, Duval S, Smolderen KG, Cohen DJ, et al. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes 2010;3:642-51.
14. Jonsson B. Revealing the cost of type II diabetes in Europe. Diabetologia 2002;45:S5-12.
15. Koster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM study. Diabetologia 2006;49:1498-504. (Pubitemid 43848085)
16. Escaned J, Rydén L, Zamorano JL, Poole-Wilson P, Fuster V, Gitt A, et al. Trends and contexts in European cardiology practice for the next 15 years: the Madrid declaration: a report from the European conference on the future of cardiology, Madrid, 2e3 June 2006. Eur Heart J 2007;28:634-7. (Pubitemid 47355503)
17. Tendera M. How much does Europe invest in the treatment of cardiovascular diseases? Eur Heart J 2006;27:1521-2. (Pubitemid 43954908)
18. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006;27:1610-9. (Pubitemid 43954923)
19. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480-6.
20. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009;50:54-60.
21. Fox KA, Goodman SG, Anderson Jr FA, Granger CB, Moscucci M, Flather MD, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1414-24. (Pubitemid 36961831)
22. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Intersociety consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg Jan 2007;45(Suppl. S):S5-67.
23. McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997;12:209-15. (Pubitemid 27175894)
24. Cacoub PP, Zeymer U, Limbourg T, Baumgartner I, Poldermans D, Röther J, et al. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart 2011;97:660-7.
25. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the REduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009;204:e86-92.